The Inhibitory Mechanism of YC-1, a Benzyl Indazole, on Smooth Muscle Cell Proliferation: An In Vitro and In Vivo Study

Chieh Hsi Wu, Weng Cheng Chang, Gee Yat Chang, Sheng Chu Kuo, Che Ming Teng

研究成果: 雜誌貢獻文章

26 引文 斯高帕斯(Scopus)

摘要

The pharmacological mechanisms of a synthetic compound 1-benzyl-3-(5′ -hydroxy-methyl-2′-furyl) indazole (YC-1) in preventing smooth muscle cell proliferation remains to be elucidated. The present study was aimed to explore the effects of YC-1 on certain molecules responsible for cell proliferation, including transforming growth factor (TGF)-β1, soluble guanylyl cyclase (sGC) and focal adhesion kinase (FAK). The in vivo assay was correlated to the in vitro results of YC-1 on vascular stenosis. YC-1 was applied topically via a pluronic gel onto the balloon-injured rat carotid arteries, which were then harvested two weeks later for histological analysis. Our in vitro results showed that TGF-β1 was suppressed by YC-1 by 50%. The translational level of sGC was threefold activated by YC-1 while the transcription level of sGC was increased up to 24-fold. FAK, the molecule responsible for cell proliferation and migration, was suppressed by YC-1 on the translational levels for 72%. These in vitro results were in consistent with the in vivo observation that the area ratio of neointima to media was reduced by YC-1. This study provides insights into the pharmacological mechanisms of YC-1 in preventing abnormal smooth muscle cell proliferation and thus supports the use of YC-1 as an adjuvant therapy for balloon injury-induced restenosis.

原文英語
頁(從 - 到)252-260
頁數9
期刊Journal of Pharmacological Sciences
94
發行號3
DOIs
出版狀態已發佈 - 三月 2004
對外發佈Yes

    指紋

ASJC Scopus subject areas

  • Pharmacology

引用此